A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma

Completed · Phase 1

Conditions studied: Asthma

In brief

The purpose of this study is to assess the pharmacokinetics (PK) and safety of symbicort aerosphere and symbicort pressurized metered dose inhaler (pMDI) in participants with asthma aged 4 to less than 12 years.

Key facts

Study ID

NCT07433569

Run by

AstraZeneca

People needed

16

Starts

2026-03-05

Expected to finish

2026-06-26

Last updated by the study team

2026-07-15

Who can join

Age: 4 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research Site — Long Beach, California, United States
• Research Site — Miami, Florida, United States
• Research Site — Lafayette, Louisiana, United States
• Research Site — Toledo, Ohio, United States
• Research Site — Boerne, Texas, United States
• Research Site — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.